Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Only 19 of 159 radiation oncology professionals working across Canada, or 12%, feel they’re well-versed in AI. However, more than 90% are open to learning its ways.
The scientists focused on getting their AI to mimic the cortical mechanism of “gating,” which controls information flow between neuron clusters to apply existing knowledge to new situations.
Analyzing timestamped EHR data from more than 21 million primary care visits in 2017, researchers have ascertained average lengths of visit and other metrics useful to assessing care quality.
Oxford researchers have developed and prospectively validated two AI tools that can quickly screen hospital patients for COVID-19 using routine clinical data.
North of the border, two grants of $200,000 are on offer for researchers innovating transformative ways to apply AI in healthcare—and they’re only one part of an ambitious academic endeavor to expand medical AI.
The COVID crisis has pushed healthcare providers to up their game on digital health, but the sector is not moving fast enough on this front for the liking of healthcare consumers.
More than 105 exhibitors presented AI-specific wares in the virtual AI showcase. That was down from 2019’s pre-COVID 150 but still easily beat 2018’s head count, around 75.
